KOTOBAKARI Study: Using Natural Language Processing of Patient Short Narratives to Detect Cancer Related Cognitive Impairment.
Recent reports of some studies have described that the cognitive function of cancer patients often declines by a phenomenon designated as cancer related cognitive impairment (CRCI). For patients' decision-making, detecting CRCI is important. To do so, this study uses language-based CRCI screening to examine participants' language ability. This study was conducted to ascertain whether a Natural Language Processing (NLP) based system can detect CRCI, or not. We obtained materials of two types from cancer patients (n = 116): (1) speech samples on three topics, and (2) cognitive function level test scores from Hasegawa's Dementia Scale - Revised (HDS-R), a test used in Japan for dementia patients. The test is similar to the Mini-Mental State Examination. Cancer patients with lower HDS-R scores showed a significantly lower Type Token Ratio (TTR). This result demonstrates the feasibility of the proposed speech-language-based CRCI screening method.